// App-Quantinova.ai

2139 : RNA nanoparticles as a two-in-one siRNA delivery carrier synergistically suppress drug-resistance cancer via combination therapy with doxorubicin

Researchers

Presenter

  • Hyung Jun Ahn

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

  • B-cell lymphoma 2

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved